213
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Development of a new nomogram to predict insignificant prostate cancer in patients undergoing radical prostatectomy

, , , , , & show all
Pages 27-32 | Received 18 Jul 2016, Accepted 21 Nov 2016, Published online: 07 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (10)

Futoshi Morokuma, Eiji Sadashima, Soutaro Chikamatsu, Tomoya Nakamura, Yusuke Hayakawa & Noriaki Tokuda. (2020) Use of increasing the number of biopsy cores in proportion to prostate size on prostate cancer diagnosis. Journal of Clinical Urology 14:5, pages 361-368.
Crossref
Zhen Chen, Zelan Xiao, Siheng Zeng & Zhiqiang Yan. (2021) The potential value of microRNA-145 for predicting prognosis in patients with ovarian cancer. Medicine 100:32, pages e26922.
Crossref
Xianghong Zhou, Qingyang Ning, Kun Jin, Tao Zhang & Xuelei Ma. (2020) Development and validation of a preoperative nomogram for predicting survival of patients with locally advanced prostate cancer after radical prostatectomy. BMC Cancer 20:1.
Crossref
Hailang Liu, Kun Tang, Ding Xia, Ejun Peng, Liang Wang & Zhiqiang Chen. (2020) Combined multiple clinical characteristics for prediction of discordance in grade and stage in prostate cancer patients undergoing systematic biopsy and radical prostatectomy. Pathology - Research and Practice 216:11, pages 153235.
Crossref
Arthur J. Swersey, John Colberg, Ronald Evans, Michael W. Kattan, Johannes Ledolter & Rodney Parker. (2019) Decision models for distinguishing between clinically insignificant and significant tumors in prostate cancer biopsies: an application of Bayes’ Theorem to reduce costs and improve outcomes. Health Care Management Science 23:1, pages 102-116.
Crossref
Wei-dong Jiang & Ping-cheng Yuan. (2019) Development and validation of prognostic nomograms for patients with metastatic prostate cancer. International Urology and Nephrology 51:10, pages 1743-1753.
Crossref
Jeong Woo Lee, Jae Young Jeong, In-Chang Cho, Sung Han Kim, Whi-An Kwon, Miyoung Choi & Jeong Kyun Yeo. (2019) The Treatments for Low-Risk Prostate Cancer. The Korean Journal of Urological Oncology 17:1, pages 7-21.
Crossref
Annika Herlemann, Samuel L. WashingtonIIIIII, Renu S. Eapen & Matthew R. Cooperberg. (2017) Whom to Treat. Urologic Clinics of North America 44:4, pages 547-555.
Crossref
Xianna Li, Aihua Zhang, Hui Sun, Zhidong Liu, Tianlei Zhang, Shi Qiu, Liang Liu & Xijun Wang. (2017) Metabolic characterization and pathway analysis of berberine protects against prostate cancer. Oncotarget 8:39, pages 65022-65041.
Crossref
James T. Kearns & Daniel W. Lin. (2017) Prediction models for prostate cancer outcomes. Current Opinion in Urology 27:5, pages 469-474.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.